Novartis AG vs STMicroelectronics NV — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while STMicroelectronics NV trades at $55.7 (market cap $49.21B). The key difference: Novartis AG is far larger — about 6× STMicroelectronics NV's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| NVS | STM | |
|---|---|---|
Market Cap | $295.37B | $49.21B |
Sector | Health | Financials |
52-Week High | $168.62 | $79.91 |
52-Week Low | $119.31 | $21.20 |
Enterprise Value | $336.69B | $47.21B |
Dividend Yield | 3.07% | 0.65% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →